Hologic's SecurViewDX breast imaging workstation:
This article was originally published in Clinica
The US FDA has cleared for sale Hologic's SecurViewDX breast imaging workstation, a dedicated, multi-modality system for displaying and interpreting any screening or diagnostic digital mammogram, and other images, such as MRI, CT, PET and ultrasound. "The ability to use our dedicated workstation to view digital mammograms from any vendor, as well as images from other modalities, should have a significant impact on improved workflow in breast imaging suites," said Jack Cumming, the Bedford, Massachusetts firm's chairman and CEO. The workstation can also support digital computer-aided detection programmes.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.